PERCEPTIVE ADVISORS LLC Q2 2024 Filing
Filed August 14, 2024
Portfolio Value
$4.2B
Holdings
110
Report Date
Q2 2024
Filing Type
13F-HR
All Holdings (110 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 101 | EGRXEAGLE PHARMACEUTICALS INC | 173,365 | $970.8B | 23118.41% | |
| 102 | LO9AVBI VACCINES INC CDA | 1,261,710 | $832.7B | 19829.50% | |
| 103 | TCMDTACTILE SYS TECHNOLOGY INC | 62,639 | $747.9B | 17809.75% | |
| 104 | SYRSSYROS PHARMACEUTICALS INC | 116,754 | $602.5B | 14345.98% | |
| 105 | —SINGULAR GENOMICS SYSTEMS IN | 70,896 | $599.1B | 14265.49% | |
| 106 | —CAREMAX INC | 122,643 | $342.2B | 8148.08% | |
| 107 | AXGNAXOGEN INC | 30,421 | $220.2B | 5244.70% | |
| 108 | RVMDWREVOLUTION MEDICINES INC | 250,000 | $25.5B | 607.82% | |
| 109 | SRZNWSURROZEN INC | 166,666 | $2.8B | 65.89% | |
| 110 | —CAREMAX INC | 60,000 | $846.0M | 20.15% |
PreviousPage 2 of 2